Brett Finlay, professor at the University of British Columbia and a researcher at the forefront of the emerging field of cellular microbiology, will present "Battling the Bugs: Confronting the Microbial Menace" at 4:15 p.m. Wednesday, April 27, in 116 Pearson Hall. The presentation, for a general audience, is the annual Orton K. Stark Lecture in Microbiology, sponsored by the department of microbiology.
Finlay, professor in the Michael Smith Laboratories, department of biochemistry and molecular biology and department of microbiology and immunology at UBC, is internationally recognized for his work in host-pathogen interactions at the molecular level.
His laboratory studies several pathogenic bacteria, primarily focusing on Salmonella and pathogenic E. coli interactions with host cells.
He is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences, is the UBC Peter Wall Distinguished Professor, and is an Officer of the Order of Canada and Order of British Columbia.
Finlay was a Howard Hughes Medical Institute International Research Scholar from 1991 to 2010 and has received numerous other awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, the Canadian Killam Health Sciences Prize and the Flavelle Medal of the Royal Society, among many others.
He is a cofounder of Inimex Pharmaceuticals Inc. and director of the SARS Accelerated Vaccine Initiative.
Finlay will also give a research seminar, “The Role of the Microbiota in Enteric Infectious Diseases” at 11 a.m. Thursday, April 28, in 218 Pearson Hall.